Mario Ernest
SEC-identified person · CIK 1180469 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Soleno Therapeutics INC SLNO | Director | filed 2014–2024 |
| Hyperion Defi, INC. HYPD | Director | filed 2018–2021 |
| Kindred Biosciences, Inc. goqxve5$ | Director | filed 2013–2021 |
| Celgene Corp /DE/ CELG | Director | filed 2007–2019 |
| Jasper Therapeutics, Inc. JSPR | Director | filed 2019–2019 |
| Tonix Pharmaceuticals Holding Corp. TNXP | Director | filed 2013–2018 |
| Chimerix INC CRMX | Director | filed 2013–2018 |
| Boston Scientific Corp bsx | Director | filed 2006–2015 |
| Xenoport INC XNPT | Director | filed 2012–2015 |
| Vivus INC vvus | Director | filed 2012–2013 |
| Maxygen INC MAXY | Director | filed 2006–2012 |
| Pharmaceutical Product Development INC PPDI | Director | filed 2006–2011 |
| Alexza Pharmaceuticals Inc. ALXA | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.